Pressure ulcers (PUs) are serious, costly and common adverse events that develop as a result of a combination of physiological factors and external conditions. In many cases they are avoidable.
Hypothesis/Aim
The aim of this rapid review was to compare the clinical effectiveness, safety and cost-effectiveness of patient-centred care versus the usual care in PU management.
Methods
A systematic search was undertaken using four databases. The paper selection, critical appraisal and data extraction were completed independently by two reviewers using standardised instruments. A meta-analysis was not possible, so the data were presented in a narrative format and by using a table summary based on the Grading of Recommendations, Assessment, Development and Evaluations approach.
Results/Findings
In this search, 417 studies were identified, and two relevant high-quality papers were included: one randomised controlled trial (RCT) and one costeffectiveness study. Although the RCT showed approximately twice the PU incidence in the control group when compared to the intervention group (patient-centred care) and an even higher incidence of stage 1 PUs, the differences were not statistically significant after making adjustments to the cluster INTRODUCTION Pressure ulcers (PUs) are serious, mostly avoidable, costly and common adverse events that develop as a result of a combination of physiological factors and external conditions. 1,2 Some of the factors influencing the PU incidence are the aging population and the increase in the number of elderly individuals living with disabilities. Learning how to manage PUs appropriately has become increasingly important for all wound care professionals. 1 The time required to develop a PU depends on many factors, including the patient's physiology, the degree of pressure and the shear force placed on the tissue. 3 It also depends on the healthcare professionals' ability to provide appropriate preventive measures. However, it has been reported that only 10.8% of the patients with PU development risks fully receive adequate prevention in bed and while sitting. 4 More than 70% of the patients  Pressure ulcers are serious, costly and common adverse events that develop as a result of a combination of physiological factors and external conditions. This rapid review compares the clinical effectiveness, safety and cost-effectiveness of patient-centred care versus the usual care in pressure ulcer management.
who are not at risk receive some PU prevention while lying or sitting. 4 So, for many patients, the basic standard of preventive care is provided (including positioning, skin care and nutrition support). However, the PU development risk level is not taken into account in every case, and the management is not always sufficiently individualised.
In the 2017 Organisation for Economic Cooperation and Development Health Ministerial Statement, the health ministers agreed on the importance of addressing health literacy barriers in order to help healthcare systems become more 'person'-centred. 5 Although there is no universally agreed upon definition of patient/person centred care (PCC), it is embedded within the paradigm of holism that views an individual as a biopsychosocial and physiological whole. 6 The major objective of PCC is to achieve a working partnership between patients and their families in relation to the delivery of healthcare services. 7 Health literacy is an important element of PCC because it supports individuals becoming partners in the co-production of their own health, and it optimises the quality of the interactions between individuals and healthcare systems. The literature shows that health literacy is positively associated with a better patient experience, improved selfcare practices and, at times, better health outcomes. 7 For the management of PUs, health literacy is the degree to which individuals have the capacity to obtain, process and understand the basic health information about PU prevention, symptomatology and services that is needed to make appropriate health decisions. In this case, the patient's involvement is crucial.
PUs are considered to be some of the most preventable adverse events, but there is still a lack of information about comprehensive and appropriate prevention strategies, especially in relation to the PCC concept (individualised level). Several PU consequences for patients as well as healthcare systems in terms of costs have been described internationally. While focusing on the healthcare costs, various countries have included hospital acquired PU (HAPU) rates as a hospital performance indicator with subsequent financial penalties8, which assumes that staffing with skilled nurses can improve the healing rate with a reduced medical cost. [8] [9] [10] However, none of the authors performed systematic/ rapid reviews in order to identify the value of PCC in PU management (both prevention and treatment). Thus, there is a need to perform a rapid review of this topic because systematic and rapid reviews are two types of studies that speed up evidence translation into practice. 11, 12 This review was approved as a rapid review, and it is registered in the PROSPERO International Prospective Register of Systematic Reviews. The record is published on PROSPERO websites under registration number CRD42019120926. The preliminary search was conducted using the MEDLINE, PROSPERO and Epistemonikos databases and platforms in order to establish whether any systematic or rapid reviews on this topic had been conducted. The search was performed in December of 2018, and no rapid or systematic reviews related to this issue were found.
This review was conducted according to an a priori protocol that was published/registered in the PROSPERO database. Outcome: The outcomes of this review were the clinical effectiveness, cost-effectiveness and safety of the PU/injury management, which was mainly measured as the incidence of newly developed PUs and the direct costs of prevention and treatment.
METHODS

Study designs
This review included experimental study designs [randomized controlled trials (RCTs) and quasi-RCTs] and cost-effectiveness studies. However, we also searched for observational analytical study designs (cohort, case-control and cross-sectional studies).
Search strategy
A three-step search strategy was used. Initial and limited searches of the Web of Science and Scopus were undertaken, followed by analyses of the keywords contained in the titles, abstracts and index terms used to describe an article. A second search using all of the identified keywords and index terms was undertaken across the Web of Science, Scopus, Ovid MEDLINE (R) and Cumulative Index to Nursing and Allied Health Literature (CINAHL) Complete databases (Appendix 1). Thirdly, the reference lists from the newly identified reports and articles were searched for additional studies. All of the studies with titles and abstracts in English were considered for inclusion, regardless of the language used in the body of the manuscript, and studies published between January 2014 and January 2019 were sought out.
The PCC concept was first introduced by the European Pressure Ulcer Advisory Panel guidelines in 2014. 14 Afterwards it was partially used in connection with a PU prevention and treatment wound care team review by the Cochrane Library that was published in 2014; however, that review had a different review question and different inclusion criteria than our review. 15 
Study records
The literature search results were uploaded to EndNote X7 (Clarivate Analytics, Philadelphia, PA, USA). The titles and abstracts of the studies retrieved using the search strategy were screened independently by two review authors (AP and ZK) to identify the studies that potentially met the inclusion criteria outlined above. The full texts of these potentially eligible studies were retrieved and independently assessed for eligibility by two review team members (AP and ZK). Any disagreements between them over the eligibility of a particular study were resolved through discussion with a third reviewer (MK).
Risk of bias
The papers selected for retrieval were assessed by two independent reviewers (MK and JK) for their methodological quality prior to their inclusion in the rapid review. The assessments were conducted using standardised critical appraisal instruments from the JBI System for the Unified Management, Assessment and Review of Information (SUMARI). 16 Any disagreements were resolved by discussion and through the consultation of a third reviewer (AP).
Data extraction
The data were independently extracted by two reviewers (AP and JK) from the studies included in the review using the standardised data extraction tools from the JBI-SUMARI. The extracted data included the following: the study setting, study population, participant demographics and baseline characteristics, details of the intervention and comparison, study methodology and outcomes relevant to the rapid review objectives. Any disagreements were resolved during the team discussions.
Data synthesis
Only one RCT and one cost-effectiveness study were included, so a meta-analysis was not possible. The findings were presented in a narrative form, including tables and figures to aid in the data presentation where appropriate.
Confidence in the evidence
Based on the results and quality of the evidence, the Grading of Recommendations, Assessment, Development and Evaluations (GRADE). 17, 18 approach was used. The evidence quality was assessed across the risk of bias, consistency, directness, precision and publication bias domains. The quality was assessed as high (further research is very unlikely to change our confidence in the estimate of the effect), moderate (further research is likely to have an important impact on our confidence in the estimate of the effect, and it may change the estimate), low (further research is very likely to have an impact on our confidence in the estimate of the effect, and it is likely to change the estimate) or very low (very uncertain about the estimate of the effect).
RESULTS
The literature search was performed using four electronic databases, and a total of 417 studies were found. In the Scopus database, 136 studies were found, 129 were found in the Web of Science database, 54 were found in the Ovid Medline database and 101 were found in the CINAHL database (Fig. 1 ). There were 87 duplicates that were identified and removed. Two independent reviewers excluded 326 studies after the analyses of the titles and abstracts. Four full texts were independently reviewed, and two of them were excluded with reasons (Appendix 2). Finally, two relevant papers 2, 19 were critically appraised, and both were included in the review.
Methodological quality
The methodological quality was determined using the JBI Critical Appraisal Checklists for RCTs and Economic Evaluation. Two authors (MK and JK) independently appraised each paper, and there were no disagreements regarding the appraisal (Tables 1 and 2 ). The overall quality of both papers was high, and the risk of bias was low.
Review findings
Only one relevant RCT paper19 and one cost effectiveness paper 2 were included in the review; however, both papers were based on one study with the same population sample (the RCT focused on the clinical perspective, while the cost effectiveness paper focused on the costs). The findings are presented in a narrative form, including tables and figures to aid in the data presentation where appropriate (Tables 3 and 5) . 
Clinical effectiveness and PCC compared to usual care
Only one RCT 19 compared PCC with usual care by assessing the clinical effectiveness and safety of patients with PUs. Chaboyer et al. 19 reported that the HAPU incidence in the control group was significantly higher when compared to the patient-centred PU prevention care bundle (PUPCB) group (Table 4) . The PUPCB was theoretically and empirically based on patient participation and the clinical practice guidelines. There were multiple components, with three messages presented to the patients for PU prevention: keep moving, look after your skin and eat a healthy diet. The training aids for the patients included a DVD, brochure and poster. The nurses in the intervention hospitals were trained to partner with their patients in their PU prevention care. As part of the PUPCB, there were no special interventions used when compared to the standard preventive strategies. The main difference was in the implementation of the preventive measures according to the patient's degree of PU risk formation. Therefore, the precise risk stratification of the patients was the most important factor that influenced the preventive measures (positioning frequency, skin inspection frequency and healthy diet).
A PUPCB consisting of multicomponent nurse training and patient education was mentioned above. However, the development of a HAPU did not differ statistically significantly between the intervention group, consisting of 49 patients (6.1%), and the control group, consisting of 84 patients (10.5%), after adjusting for clustering, but the control group had approximately twice the HAPU incidence of the PUPCB group (unadjusted hospital level data). There was no statistically significant effect of the PUPCB on the PU incidence at the participant level once the prognostic factors and clustering were accounted for. 

The authors also reported a 52% reduction in the HAPU risk associated with the intervention when compared with usual care; however, this difference was not statistically significant. In addition, this trial showed a significantly higher incidence of stage 1 HAPUs in the PUPCB group (28 patients, 3.5%) when compared to the control group (60 patients, 7.5%) ( Table 4 ). However, after adjusting for clustering, there was no significant difference between the intervention and control groups in the new PU severity. Moreover, the stage 2 incidence was almost the same between the intervention group (16 patients, 2.0%) and the control group (19 patients, 2.4%). With regard to unstageable HAPUs, 5 patients (0.6%) were identified in each group.
Cost-effectiveness of PCC compared to usual care
Only one paper 2 analysed the cost-effectiveness and cost benefits of PCC compared to usual care in patients with PU risks. This cost-effectiveness paper 2 used the same population as the abovementioned RCT. 19 The largest contributor to the prevention costs was related to the clinical nurses' time required to reposition the patients or to inspect their skin. The intervention costs also contributed substantially in the PUPCB group. Whitty et al. 2 found a significant difference between the groups in the costs associated with skin inspection, which were a mean of $44.27 more costly in the PUPCB group than the usual care group (p=0.014). The other PUPCB strategy products (keep moving and a healthy diet) contributed relatively little to the costs, but the time spent positioning the patient was higher in the intervention group (p=0.343). This paper 2 also showed that the PUPCB was associated with an increased number of days free from PUs per participant (mean difference of 1.12 days per patient, 95% confidence interval of 0.34 to 1.82) (Table 5) . However, the PUPCB may be cost-effective when making reasonable assumptions about the willingness to pay thresholds for a PU prevented ($3.786). Based on the cost-benefit analysis, the PUPCB was significantly costlier for a significantly less benefit than usual care, suggesting that the PUPCB was not a cost-effective use of resources. In addition, the comparison of the lengths of stay (LOSs) confirmed that the PUPCB (mean LOS of 6 days) was not cost-effective when compared to the control group (mean LOS of 5 Four clusters were randomised to each group, and 799 patients per group were analysed (intervention/control). Random number generating software was used to randomise the hospitals (clusters) within the strata with a random 1:1 block allocation of hospitals to the intervention or control groups. Pressure ulcers present at the baseline in 60 (7.7%) patients in the intervention group and 95 (12.0%) patients in the control group.
Primary outcomes were the incidence of hospital-acquired pressure ulcers measured in the cluster and the individual participant level by the daily skin inspection. Secondary outcomes were the severity of the hospital-acquired pressure ulcers classified according to the International Pressure Ulcer Classification System and the patient participation in the pressure ulcer prevention.
The pressure ulcer prevention care bundle was associated with a large reduction in the hazard of ulceration (the difference was not statistically significant).
Cost-effectiveness and cost-benefit study Australia 1,600 adults >18 years old; medical and surgical patients at risk of pressure ulcer due to limited mobility; expected to stay in the hospital > 48 h; across eight tertiary hospital sites in Australia Four clusters were randomised to each group, and 799 patients per group were analysed. Random number generating software was used to randomise the hospitals (clusters) within strata with a random 1:1 block allocation of hospitals to the intervention or control groups. Pressure ulcers present at the baseline in 60 (7.7%) patients in the intervention group and 95 (12.0%) patients in the control group.
Cost-effectiveness analyses: Primary outcomes were the incremental costs of prevention per additional hospital-acquired pressure ulcer/incidence of a hospital acquired pressure ulcer of any stage versus the hospital-acquired pressure ulcer cases prevented, delay in developing a hospital-acquired pressure ulcer and the days free from hospital-acquired pressure ulcers versus the costs associated with the length of stay. Cost-benefit analyses: Primary outcomes were the costs of prevention and any difference in the length of stay and any day reduction in the length of stay with an Australian -Diagnosis Related Group.
A pressure ulcer prevention care bundle consisting of multicomponent nurse training and patient education may promote best practice nursing care, but it may not be cost-effective for preventing hospital acquired pressure ulcers. Tables 4 and  5 , due to the low level of events (respectively, participants in clusters), we used the GRADE approach to move one grade down due to the imprecision of the results. We also used the GRADE approach to move one more grade down due to the risk of publication bias of this rapid review; therefore, the level of evidence of this review was graded with low certainty in the outcomes.
There were some differences in the baseline characteristics between the groups; for example, a lower number of patients were admitted from assisted living facilities in the intervention group. These patients were more likely to have neurological comorbidities, less likely to have cancer and less likely to have PUs at the baseline than the control group. Although the authors adjusted for these differences, they might have limited the results. days); even the exclusion of the outliers did not change the results (Table 5) .
DISCUSSION
This rapid review identified only two relevant papers that conducted research using the same population. One paper described an RCT19 dealing with clinical effectiveness and one described cost-effectiveness and cost-benefit analyses. 2 The RCT compared PCC with usual care, and the HAPU incidence was measured using the clinical standard skin inspection methods. 19 The limitation of relying on the medical record documentation for the presence of a PU was overcome by the prospective and daily outcome assessments.
Although the control group had almost twice the HAPU incidence when compared to the intervention group based on the analyses of the unadjusted data, if the data were adjusted to a hospital level, there was no statistically signifi-This paper 2 also showed that the intervention was associated with an increased number of days free from PUs per participant. The intervention may be cost-effective when making reasonable assumptions around the willingness to pay thresholds for a PU prevented; however, based on the cost-benefit analysis, the intervention was significantly costlier for significantly less benefit than usual care, suggesting that the care bundle was not a cost-effective use of resources. It is clear from this that it is very important to choose the patients on whom the PUPCB is used. The PUPCB is expensive for patients without PU risks; however, it is beneficial for patients with high PU risks. 2, 19 Although the findings were inconclusive, the PUPCB was based on the current best evidence, suggesting that it may be a tool that nurses can use to assist them in providing PCC. The main PUPCB roles should be seen in the nurse's education as well as in patient training to help them better understand PUs or help them to participate in PU prevention.
Study limitations
This study was a rapid review designed to show the best available evidence in a rapid way. This was not as robust of a study design as a systematic review, which is the biggest 
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect. Moderate certainty: We are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect Very low certainty: We have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of the effect.
FURTHER RESEARCH
Future research from different healthcare systems (different standards of care provided by the nurses) should investigate the patient reported outcomes and PCC satisfaction with regard to PU and injury management, especially in high risk patients.
Moreover, there is a need to explore objective and valid tools for determining patient outcomes and evaluating their satisfaction with PU management.
